FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
24/06/2026
Voltar para busca
Dado oficial do USPTO
WASKYRA
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
19
Atualização mais recente
24/06/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42, 44
Data de depósito
03/06/2025
Data de registro
24/03/2026
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
24/03/2026
Última transação
24/06/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
IT
Examinador
OSGOOD, KRYSTINA E
Unidade examinadora
N30
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
F. E. (pessoa física)
Representantes
Michael J. Leonard Fox Rothschild LLP
Classificação técnica
Classes Nice
Classe 5Classe 42Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for gene therapy for the treatment of Wiskott-Aldrich syndrome; medicineEtuvetidigene autotemcel; pharmaceutical preparations for treating Wiskott-Aldrich syndrome
Classe 42
Biological researchclinical research in the field of gene therapy and medical research; medical research laboratory services; research and development of vaccines and medicines; scientific research services in the preparation of biological samples for testing and analysis in research laboratories; genetic scientific research; scientific research and development; pharmaceutical drug development services; providing information on clinical studies via an interactive website; medical and scientific researchconducting clinical trials for others; DNA screening for scientific research purposes; design and development of computer hardware and software; research and development of new products for others; conducting technical scientific feasibility project studies; rental of computer software for collectinganalysing and organizing data in the field of medical research and treatment of genetic diseases; computer programming; conversion of computer programs and dataother than physical conversion; recovery of computer data; quality control for others; material testing; engineeringsurveying; conversion of data or documents from physical to electronic media; bacteriological research; hosting of communication computer platforms on the internet; programming of software for Internet platforms; pharmaceutical products development; scientific research services; scientific laboratory services; structural and functional analysis of genomes; development of pharmaceutical preparations and medicines; scientific research consultancy in relation to assessmentsestimatesresearches in science and technology rendered by engineers; providing information in the nature of evaluations and estimations in the field of medical research; industrial research and biological analysis in the field of health; providing of imaging and physiology platformsproviding temporary use of online non-downloadable software for analysing medical imaging; research and development of pharmaceuticals and veterinary and hygiene preparations for others; product development and testing of pharmaceuticals in the validation of biological testscellular testsgenetic tests and immunological tests; gene therapy research and scientific research
Classe 44
Medical services; medical screening; medical assistance; medical counselling; providing news and information in the field of medicine; performing diagnosis of diseases; medical advisory services relating to degenerative diseases; medical surgical diagnostic services; medical analysis services for diagnostic and treatment purposes provided by medical laboratories; medical diagnostic services; human hygiene and beauty care; health counselling; hospital services; nursing home services; pharmacy adviceprescription management and reviews; medical imaging services; human tissue bank services; conducting of medical examinations; medical consultations; medical and health care services relating to DNAgenetics and genetic testing; telemedicine services; stem cell therapy services; preparation and dispensing of medications; providing of medical information in the pharmaceutical field; medicalalternative medicinal and pharmaceutical consultancy
Publicações
Histórico de despachos e eventos da marca no USPTO.
19 publicações encontradas
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
24/03/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
24/03/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/02/2026
PUBO
PUBLISHED FOR OPPOSITION
03/02/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28/01/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/01/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/12/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/12/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
24/12/2025
RFNT
REFUSAL PROCESSED BY IB
18/12/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
04/12/2025
RFRR
REFUSAL PROCESSED BY MPU
04/12/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
22/10/2025
CNRT
NON-FINAL ACTION WRITTEN
21/10/2025
DOCK
ASSIGNED TO EXAMINER
21/10/2025
MAFR
APPLICATION FILING RECEIPT MAILED
25/08/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
25/08/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
21/08/2025
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace WASKYRA ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.